Published in Circ Heart Fail on January 07, 2011
Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol (2013) 1.78
Prospective study of the association between dispositional optimism and incident heart failure. Circ Heart Fail (2014) 1.60
Heart failure in a cohort of patients with chronic kidney disease: the GCKD study. PLoS One (2015) 1.42
Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels (2011) 1.04
The natural history of preclinical diastolic dysfunction: a population-based study. Circ Heart Fail (2012) 1.02
Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail (2014) 0.99
Obesity and heart failure as a mediator of the cerebrorenal interaction. Contrib Nephrol (2013) 0.78
Acute kidney injury after valvular heart surgery and early changes in cardiac function and structure. Cardiorenal Med (2014) 0.75
High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4. Medicine (Baltimore) (2016) 0.75
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study. Clin Epidemiol (2016) 0.75
Use of Electronic Health Data to Estimate Heart Failure Events in a Population-Based Cohort with CKD. Clin J Am Soc Nephrol (2016) 0.75
Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease. Curr Opin Nephrol Hypertens (2015) 0.75
The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail (2017) 0.75
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA (2005) 5.46
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol (2000) 4.21
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol (2002) 3.92
Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation (2005) 3.86
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Premature cardiovascular disease in chronic renal failure. Lancet (2000) 3.17
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA (2009) 2.90
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis (1999) 2.65
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation (2006) 2.35
Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis (1996) 2.33
Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int (2002) 2.32
Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol (1991) 1.60
Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol (2001) 1.58
Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study. Arch Intern Med (2006) 1.54
Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol (2000) 1.52
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis (2005) 1.49
Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int (2003) 1.17
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int (2004) 1.16
Analgesic use and renal function in men. JAMA (2001) 1.13
Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol (2003) 1.09
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS). Am Heart J (2007) 1.04
Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study. Am Heart J (2008) 0.93
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Physical activity and weight gain prevention. JAMA (2010) 5.27
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53
The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst (2008) 3.40
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37
A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32
Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst (2002) 3.03
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90
Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA (2009) 2.90
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77
Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation (2005) 2.73
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72
Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Intern Med (2008) 2.67
Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study. Am J Clin Nutr (2008) 2.61
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med (2011) 2.43
A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens (2007) 2.43
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA (2008) 2.32
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Dietary fiber intake and cardiometabolic risks among US adults, NHANES 1999-2010. Am J Med (2013) 2.27
Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr (2010) 2.25
A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst (2004) 2.22
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med (2007) 2.20
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation (2008) 2.19
Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr (2012) 2.14
Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care (2008) 2.14
Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst (2008) 2.07
Healthy lifestyle and the risk of stroke in women. Arch Intern Med (2006) 2.02
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res (2005) 1.98
Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med (2002) 1.97
Alcohol consumption and the risk of hypertension in women and men. Hypertension (2008) 1.96
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics (2004) 1.95
Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States. Stroke (2007) 1.91
A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen. Clin Trials (2011) 1.91
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Nut consumption and risk of hypertension in US male physicians. Clin Nutr (2008) 1.88
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet (2003) 1.85
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81
Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol (2009) 1.79
Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr (2003) 1.79
Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol (2008) 1.74
Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med (2002) 1.73
Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation (2006) 1.68
Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med (2007) 1.67
Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut (2012) 1.66
Smoking and risk of hemorrhagic stroke in women. Stroke (2003) 1.63
Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol (2010) 1.60
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. Nephrol Dial Transplant (2006) 1.59
Statin use and fracture risk: study of a US veterans population. Arch Intern Med (2005) 1.58
Chronic disease in men with newly diagnosed cancer: a nested case-control study. Am J Epidemiol (2010) 1.58
Dyslipidemia and the risk of incident hypertension in men. Hypertension (2005) 1.54
Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension (2006) 1.53
Statins and prostate cancer diagnosis and grade in a veterans population. J Natl Cancer Inst (2011) 1.49
Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology (2009) 1.48
A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation. J Am Coll Nutr (2012) 1.47
Effect of treating erectile dysfunction on management of systolic hypertension. Am J Cardiol (2007) 1.46
Alcohol consumption and mortality in men with preexisting cerebrovascular disease. Arch Intern Med (2003) 1.45
Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study. Int J Stroke (2014) 1.45
Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation (2003) 1.44
Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc (2008) 1.44
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One (2011) 1.41
Development of a risk score for colorectal cancer in men. Am J Med (2007) 1.39